Literature DB >> 25740554

Binding hotspots on K-ras: consensus ligand binding sites and other reactive regions from probe-based molecular dynamics analysis.

Priyanka Prakash1, John F Hancock, Alemayehu A Gorfe.   

Abstract

We have used probe-based molecular dynamics (pMD) simulations to search for interaction hotspots on the surface of the therapeutically highly relevant oncogenic K-Ras G12D. Combining the probe-based query with an ensemble-based pocket identification scheme and an analysis of existing Ras-ligand complexes, we show that (i) pMD is a robust and cost-effective strategy for binding site identification, (ii) all four of the previously reported ligand binding sites are suitable for structure-based ligand design, and (iii) in some cases probe binding and expanded sampling of configurational space enable pocket expansion and increase the likelihood of site identification. Furthermore, by comparing the distribution of hotspots in nonpocket-like regions with known protein- and membrane-interacting interfaces, we propose that pMD has the potential to predict surface patches responsible for protein-biomolecule interactions. These observations have important implications for future drug design efforts and will facilitate the search for potential interfaces responsible for the proposed transient oligomerization or interaction of Ras with other biomolecules in the cellular milieu.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  allosteric sites; drug design; probe-based molecular dynamics simulation

Mesh:

Substances:

Year:  2015        PMID: 25740554      PMCID: PMC4400267          DOI: 10.1002/prot.24786

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  67 in total

1.  Structural evidence for feedback activation by Ras.GTP of the Ras-specific nucleotide exchange factor SOS.

Authors:  S Mariana Margarit; Holger Sondermann; Brian E Hall; Bhushan Nagar; Andre Hoelz; Michelle Pirruccello; Dafna Bar-Sagi; John Kuriyan
Journal:  Cell       Date:  2003-03-07       Impact factor: 41.582

2.  Solution structure of the state 1 conformer of GTP-bound H-Ras protein and distinct dynamic properties between the state 1 and state 2 conformers.

Authors:  Mitsugu Araki; Fumi Shima; Yoko Yoshikawa; Shin Muraoka; Yuichi Ijiri; Yuka Nagahara; Tomoya Shirono; Tohru Kataoka; Atsuo Tamura
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

3.  Detection of high incidence of K-ras oncogenes during human colon tumorigenesis.

Authors:  K Forrester; C Almoguera; K Han; W E Grizzle; M Perucho
Journal:  Nature       Date:  1987 May 28-Jun 3       Impact factor: 49.962

Review 4.  Drugging the undruggable RAS: Mission possible?

Authors:  Adrienne D Cox; Stephen W Fesik; Alec C Kimmelman; Ji Luo; Channing J Der
Journal:  Nat Rev Drug Discov       Date:  2014-10-17       Impact factor: 84.694

5.  Metal-bis(2-picolyl)amine complexes as state 1(T) inhibitors of activated Ras protein.

Authors:  Ina C Rosnizeck; Michael Spoerner; Tobias Harsch; Sandra Kreitner; Daniel Filchtinski; Christian Herrmann; Daniel Engel; Burkhard König; Hans Robert Kalbitzer
Journal:  Angew Chem Int Ed Engl       Date:  2012-09-20       Impact factor: 15.336

6.  Conformational states of human rat sarcoma (Ras) protein complexed with its natural ligand GTP and their role for effector interaction and GTP hydrolysis.

Authors:  Michael Spoerner; Constantin Hozsa; Johann A Poetzl; Kerstin Reiss; Petra Ganser; Matthias Geyer; Hans Robert Kalbitzer
Journal:  J Biol Chem       Date:  2010-10-11       Impact factor: 5.157

7.  Trapping moving targets with small molecules.

Authors:  Gregory M Lee; Charles S Craik
Journal:  Science       Date:  2009-04-10       Impact factor: 47.728

8.  Andrographolide derivatives inhibit guanine nucleotide exchange and abrogate oncogenic Ras function.

Authors:  Harrison J Hocker; Kwang-Jin Cho; Chung-Ying K Chen; Nandini Rambahal; Sreenivasa Rao Sagineedu; Khozirah Shaari; Johnson Stanslas; John F Hancock; Alemayehu A Gorfe
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-04       Impact factor: 11.205

9.  Novel allosteric sites on Ras for lead generation.

Authors:  Barry J Grant; Suryani Lukman; Harrison J Hocker; Jaqueline Sayyah; Joan Heller Brown; J Andrew McCammon; Alemayehu A Gorfe
Journal:  PLoS One       Date:  2011-10-25       Impact factor: 3.240

10.  A comprehensive survey of Ras mutations in cancer.

Authors:  Ian A Prior; Paul D Lewis; Carla Mattos
Journal:  Cancer Res       Date:  2012-05-15       Impact factor: 12.701

View more
  24 in total

Review 1.  Biology, pathology, and therapeutic targeting of RAS.

Authors:  J Matthew Rhett; Imran Khan; John P O'Bryan
Journal:  Adv Cancer Res       Date:  2020-07-09       Impact factor: 6.242

2.  Distinct dynamics and interaction patterns in H- and K-Ras oncogenic P-loop mutants.

Authors:  Abdallah Sayyed-Ahmad; Priyanka Prakash; Alemayehu A Gorfe
Journal:  Proteins       Date:  2017-05-31

Review 3.  Driving Structure-Based Drug Discovery through Cosolvent Molecular Dynamics.

Authors:  Phani Ghanakota; Heather A Carlson
Journal:  J Med Chem       Date:  2016-08-17       Impact factor: 7.446

4.  Probing the Conformational and Energy Landscapes of KRAS Membrane Orientation.

Authors:  Priyanka Prakash; Alemayehu A Gorfe
Journal:  J Phys Chem B       Date:  2019-10-09       Impact factor: 2.991

5.  Application of Site-Identification by Ligand Competitive Saturation in Computer-Aided Drug Design.

Authors:  Himanshu Goel; Anthony Hazel; Wenbo Yu; Sunhwan Jo; Alexander D MacKerell
Journal:  New J Chem       Date:  2021-11-29       Impact factor: 3.591

6.  Inhibition of RAS: proven and potential vulnerabilities.

Authors:  Mariyam Zuberi; Imran Khan; John P O'Bryan
Journal:  Biochem Soc Trans       Date:  2020-10-30       Impact factor: 5.407

7.  Oncogenic K-Ras Binds to an Anionic Membrane in Two Distinct Orientations: A Molecular Dynamics Analysis.

Authors:  Priyanka Prakash; Yong Zhou; Hong Liang; John F Hancock; Alemayehu A Gorfe
Journal:  Biophys J       Date:  2016-03-08       Impact factor: 4.033

Review 8.  Therapeutic targeting of RAS: New hope for drugging the "undruggable".

Authors:  Imran Khan; J Matthew Rhett; John P O'Bryan
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2019-10-31       Impact factor: 4.739

9.  Approaches to inhibiting oncogenic K-Ras.

Authors:  Alemayehu A Gorfe; Kwang-Jin Cho
Journal:  Small GTPases       Date:  2019-08-22

10.  Molecular Dynamics Simulation of Lipid-Modified Signaling Proteins.

Authors:  Vinay V Nair; Alemayehu A Gorfe
Journal:  Methods Mol Biol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.